Bio-IT World News
YouTube Facebook LinkedIn TwitterInstagram rss
a-divisiion-of-chi
  • Subscribe
  • News
    • Latest News
    • View Press Releases
    • Post a Press Release
    • Reprint Articles
  • Podcast
  • Advertise
    • Media Kit
    • Digital Advertising
    • Lead Generation
    • Editorial Calendar
    • Webinars
    • Whitepapers
    • Podcasts
    • View Press Releases
    • Post a Press Release
  • Free Downloads
    • Whitepapers
    • Podcasts
    • Webinars
    • Inside eBooks
  • Events
    • Webinars
    • Industry Events
    • IT Conferences
    • Bio-IT World Expo
    • Bio-IT World Expo Europe
  • About Us
    • Editorial Profile
    • Editorial Calender
    • Contact Us
    • Submit a story
    • Innovative Practices Awards
    • Linking Policy
  • Bio-IT World Expo
    • Bio-IT World Boston
    • Bio-IT World Europe
 
 
 
 
  • Cycle Pharmaceuticals and Inceptua Group Expand the Free Goods Programme for Patients with Hereditary Tyrosinemia Type 1 (HT-1) and Alkaptonuria (AKU) to Include Morocco and Egypt

    Jan 12, 2026, 09:02 AM by
    Cycle and Inceptua have announced the expansion of their partnership to make NITYR® tablets available via a Free Goods Programme for eligible patients with HT-1 and AKU to include Morocco and Egypt.
    Full story
  • Aragen Launches CHOMax™, an Accelerated Platform for DNA to IND-Enabling Clinical Supply in ~10 Months

    Jan 12, 2026, 09:02 AM by
    Full story
  • Verista Expands Automation and Validation Capabilities with Acquisition of Integral Solutions

    Jan 9, 2026, 08:48 AM by
    Verista, a leading provider of automation, compliance, and quality solutions for the life sciences industry, announced the acquisition of Integral Solutions. Based in Columbus, OH, Integral Solutions is a life sciences business and technology services firm that specializes in engineering and validation services worldwide. The acquisition enhances Verista’s capabilities in automation, engineering, project management, and validation, enabling the company to deliver further comprehensive support across the full lifecycle of regulated life sciences operations.
    Full story
  • Veeva Announces Environmental Monitoring Solution to Modernize Quality Control in Manufacturing

    Jan 9, 2026, 08:48 AM by
    Full story
  • Codexis Expands Reach of the ECO Synthesis® Manufacturing Platform through a Signed Evaluation Agreement with Axolabs for Oligonucleotide Therapeutics 

    Jan 9, 2026, 08:48 AM by
    Full story
  • TechBio Survey Shows a Mixed Industry Outlook, Claude Gaining Ground, More Machine Learning

    Jan 9, 2026, 01:00 AM by User Not Found
    Bio-IT World | The Bits in Bio Slack-first community has released its fourth annual State of TechBio survey results. Year over year findings include a jump in Claude usage, an increase in daily machine learning work, and a serious cooling of the “Very bullish" sentiment across the broader biotech market.
    Full story
  • PSI Expands Toronto Operations with New Office and Appoints David Allen as Canada Country Manager

    Jan 8, 2026, 09:13 AM by
    Full story
  • Somite Becomes Cellular Intelligence, as It Builds the First Universal Virtual Cell-Signaling Model

    Jan 8, 2026, 09:13 AM by
    New white paper details key technical milestones and validation of the company’s proprietary, capsule-based platform to accelerate breakthroughs across human health
    Full story
  • Nuclera eProtein Discovery System installed at leading Universities in Taiwan

    Jan 8, 2026, 09:13 AM by
    ● Installations at National Taiwan University and National Cheng Kung University expand Nuclera’s global footprint with first commercial sales in Asia ● System strengthens Taiwan’s capabilities in protein drug discovery research
    Full story
  • PharmaForceIQ Acquires Aktana to Deliver Unparalleled Cross-Functional Engagement Impact for Pharma

    Jan 7, 2026, 09:18 AM by
    PharmaForceIQ has announced its acquisition of Aktana, aligning its cutting-edge digital orchestration platform with the industry’s premier AI-driven field Next-Best-Action (NBA) platform.
    Full story
  • Panther Life Sciences Opens Next-Generation Microarray Patch (MAP) Platform to Pharma and Biotech Partners for Co-Development of Advanced Therapies

    Jan 7, 2026, 09:18 AM by
    Panther is inviting pharmaceutical and biotechnology partners to co-develop higher-efficacy, lower-toxicity, shelf-stable therapies using its next-generation MAP platform, ahead of the 2026 JPMorgan Healthcare Conference.
    Full story
  • Systems Biology Map for Advancing the Translation of Extracellular Vesicles

    Jan 7, 2026, 01:01 AM by User Not Found
    Bio-IT World | Extracellular vesicles (EVs) are the master communicators of multicellular life, key in orchestrating the complex signaling networks that define physiology. A new multiomics study has now revealed their molecular cargo via EVMap, a high-resolution blueprint of the proteins and lipids in human circulating EVs providing a practical pathway forward across basic, translational and clinical applications.
    Full story
  • Insilico Medicine’s IPO, Servier Pharma Deal

    Jan 6, 2026, 14:17 PM by User Not Found
    Bio-IT World | On December 30, Insilico Medicine successfully listed on the Hong Kong Stock Exchange. This initial public offering (IPO) raised a total of HKD 2.277 billion ($292 billion), achieving the largest biotech IPO in Hong Kong in 2025.
    Full story
  • TeleTracking Appoints Derek Ritchea as Chief Strategy Officer

    Jan 6, 2026, 09:22 AM by
    Full story
  • Trendspotting: Artificial Intelligence, Impact of Global Policies, Data Harmonization

    Jan 6, 2026, 01:01 AM by User Not Found
    Bio-IT World | To kick off 2026, we spoke with industry experts and leaders in the Bio-IT World community about what they expect and look forward to in the new year. Here are the full trends and predictions, including more on AI, drug development, global policies, cancer treatments, and more.
    Full story
  • Top Stories of 2025: AI for Research, Innovative Practices, Digital Twins

    Dec 29, 2025, 01:01 AM by User Not Found
    Bio-IT World | In the Bio-IT World year, focus continues to be paid to pharma’s research choices and the latest in sequencing technologies. AI models for protein structure prediction have had a good year, and natural materials, psilocybin in particular, have garnered attention.
    Full story
  • Follow the Money: Molecular Glue Degrader, Physical AI Scientists, TNF Programs

    Dec 23, 2025, 01:01 AM by User Not Found
    Bio-IT World | TRIANA will continue development of their molecular glue degrader to clinical proof; Medra’s Physical AI autonomously allows scientists to adapt workflows through natural-language instructions; PsiThera will advance their Tumor Necrosis Factor superfamily preclinical programs; and more.
    Full story
  • Thermo Fisher’s New Devices, LabGenius, Sanofi Collaboration, Singapore-MIT Alliance Launches New Project

    Dec 22, 2025, 01:01 AM by User Not Found
    Bio-IT World | Thermo Fisher Scientific has introduced the Thermo Scientific X and S Series Centrifuges; LabGenius has entered a second collaboration with Sanofi; the Singapore-MIT Alliance for Research and Technology has launched a new collaborative research project; and more.
    Full story
  • CHITOSE and FUJIFILM Biosciences Form Strategic Alliance to Drive Global Innovation and Biopharmaceutical Manufacturing

    Dec 19, 2025, 09:15 AM by
    Collaboration formed to accelerate biopharmaceutical manufacturing combining high performing CHO-MK cells and GMP-manufactured culture media
    Full story
  • ZeOmega Recognized in 2025 Gartner® Market Guide for U.S. Healthcare Payer Care Management Workflow Applications

    Dec 18, 2025, 10:04 AM by
    Full story
  • 1
  • 2
  • 3
  • 4 (current)
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • »
 
CHI | Cambridge HealthTech Institute

250 First Avenue, Suite 300
Needham, MA 02494

P: 781.972.5400
F: 781.972.5425
E: chi@healthtech.com

Life Science Portals

Biological Therapeutic Products

Biomarkers & Diagnostics

Biopharma Strategy

Bioprocess & Manufacturing

Chemistry

Clinical Trials &
Translational Medicine

Drug & Device Safety

Drug Discovery & Development

Drug Targets

Healthcare

IT, AI, ML & Informatics

Technology & Tools For
Life Science

Therapeutic Indications

Venture, Innovation & Partnering

CHI Divisions

Conferences

Reports & Market Research

News & Advertising

Professional Services

Corporate Information

Cambridge Innovation
Institute

Executive Team

Testimonials

Mailing List

Careers


Request Information

Privacy Policy